IMAC Holdings, Inc. (BACK)
USD 0.04
(45.21%)
USD 0.04
(45.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -6.37 Million USD | 99.94% |
| 2022 | -9.84 Million USD | 1.01% |
| 2021 | -9.94 Million USD | -53.71% |
| 2020 | -6.47 Million USD | -4.64% |
| 2019 | -6.18 Million USD | -74.17% |
| 2018 | -3.55 Million USD | -288.1% |
| 2017 | -915.06 Thousand USD | -317.75% |
| 2016 | -219.04 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -408.63 Thousand USD | -125.54% |
| 2023 Q1 | -2.25 Million USD | 9.37% |
| 2023 Q3 | -2.89 Million USD | -109.83% |
| 2023 Q2 | -1.38 Million USD | 38.77% |
| 2023 FY | -2.94 Million USD | 70.13% |
| 2023 Q4 | 1.6 Million USD | 155.22% |
| 2022 Q1 | -3.09 Million USD | -8.7% |
| 2022 Q4 | -2.48 Million USD | 60.79% |
| 2022 FY | -9.84 Million USD | 1.01% |
| 2022 Q3 | -6.34 Million USD | -259.29% |
| 2022 Q2 | -1.76 Million USD | 42.97% |
| 2021 Q4 | -2.84 Million USD | -2.25% |
| 2021 Q3 | -2.78 Million USD | -15.5% |
| 2021 FY | -9.94 Million USD | -53.71% |
| 2021 Q1 | -2.04 Million USD | -40.22% |
| 2021 Q2 | -2.41 Million USD | -17.75% |
| 2020 Q4 | -1.46 Million USD | -11.75% |
| 2020 FY | -6.47 Million USD | -4.64% |
| 2020 Q3 | -1.3 Million USD | 23.5% |
| 2020 Q1 | -1.99 Million USD | -82.67% |
| 2020 Q2 | -1.7 Million USD | 14.27% |
| 2019 Q2 | -1.94 Million USD | -44.31% |
| 2019 FY | -6.18 Million USD | -74.17% |
| 2019 Q4 | -1.09 Million USD | 33.34% |
| 2019 Q3 | -1.63 Million USD | 15.61% |
| 2019 Q1 | -1.34 Million USD | -60.57% |
| 2018 Q1 | -583.96 Thousand USD | -122.94% |
| 2018 FY | -3.55 Million USD | -288.1% |
| 2018 Q4 | -837.39 Thousand USD | 30.92% |
| 2018 Q3 | -1.21 Million USD | -32.08% |
| 2018 Q2 | -917.8 Thousand USD | -57.17% |
| 2017 Q1 | -168.03 Thousand USD | 0.0% |
| 2017 Q2 | -331.45 Thousand USD | -97.25% |
| 2017 Q3 | -153.63 Thousand USD | 53.65% |
| 2017 FY | -915.06 Thousand USD | -317.75% |
| 2017 Q4 | -261.94 Thousand USD | -70.5% |
| 2016 FY | -219.04 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 101.258% |
| Addus HomeCare Corporation | 90.95 Million USD | 107.009% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 167.231% |
| Amedisys, Inc. | 156.39 Million USD | 104.077% |
| Astrana Health, Inc. | 84.61 Million USD | 107.535% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 178.983% |
| biote Corp. | 28.65 Million USD | 122.248% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 48.184% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 105.656% |
| COMPASS Pathways plc | -136.91 Million USD | 95.344% |
| DocGo Inc. | 15.05 Million USD | 142.348% |
| The Ensign Group, Inc. | 255.36 Million USD | 102.497% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 110.224% |
| InnovAge Holding Corp. | -23.18 Million USD | 72.496% |
| The Joint Corp. | -2.07 Million USD | -207.537% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 96.629% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 59.401% |
| ModivCare Inc. | -139.94 Million USD | 95.444% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 15192.818% |
| Option Care Health, Inc. | 314.59 Million USD | 102.027% |
| P3 Health Partners Inc. | -167.86 Million USD | 96.202% |
| P3 Health Partners Inc. | -167.86 Million USD | 96.202% |
| The Pennant Group, Inc. | 25.16 Million USD | 125.331% |
| Surgery Partners, Inc. | 328 Million USD | 101.944% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -120.789% |
| Talkspace, Inc. | -23.2 Million USD | 72.53% |
| Talkspace, Inc. | -23.2 Million USD | 72.53% |
| The Oncology Institute, Inc. | -77.01 Million USD | 91.722% |
| The Oncology Institute, Inc. | -77.01 Million USD | 91.722% |